| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6103262 | PFIZER | Modified-release metronidazole compositions and methods for making and using same |
Aug, 2017
(6 years ago) | |
Flagyl Er is owned by Pfizer.
Flagyl Er contains Metronidazole.
Flagyl Er has a total of 1 drug patent out of which 1 drug patent has expired.
Expired drug patents of Flagyl Er are:
- US6103262
Flagyl Er was authorised for market use on 26 November, 1997.
Flagyl Er is available in tablet, extended release;oral dosage forms.
Flagyl Er can be used as method of treating bacterial vaginosis.
The generics of Flagyl Er are possible to be released after 15 August, 2017.
Drugs and Companies using METRONIDAZOLE ingredient
Market Authorisation Date: 26 November, 1997
Treatment: Method of treating bacterial vaginosis
Dosage: TABLET, EXTENDED RELEASE;ORAL
More Information on Dosage
FLAGYL ER family patents
